You are viewing: China AI in Precision Medicine Market analysis

The China AI in Precision Medicine Market was valued at $4.21 Million in 2024 and projected to reach to $19.13 Million by 2029, representing a compound annual growth rate of CAGR 22.3%. China's AI in Precision Medicine market is poised for exceptional growth over the next five years, supported by substantial government investments in healthcare digitalization and artificial intelligence infrastructure.

China AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China AI in Precision Medicine Market Trends and Insights

  • This represents a compound annual growth rate of 22.3%, driven by China's substantial investments in healthcare digitalization and artificial intelligence infrastructure.
  • China's government initiatives, coupled with rising healthcare expenditure and increasing adoption of AI-powered diagnostic tools, position the country as a critical growth engine within the Asia Pacific region. The precision medicine sector in China is benefiting from accelerated digital transformation across hospitals and research institutions.
  • China's emphasis on personalized treatment approaches and genomic sequencing technologies is creating significant demand for AI-enabled solutions.
  • Between 2024 and 2029, China is expected to see widespread integration of machine learning algorithms in clinical decision-making, drug discovery, and patient stratification, reflecting the nation's commitment to modernizing its healthcare ecosystem. China's competitive advantages include a large patient population, substantial venture capital investment, and government support for biotech innovation.
  • The market's trajectory underscores China's pivotal role in reshaping global precision medicine standards and demonstrates the country's capacity to scale AI healthcare solutions rapidly across diverse medical applications..

Key Market Statistics

  • CAGR (2024-2029) CAGR 22.3%
  • Market Size, 2024 ~USD 4.21 Million
  • Forecast, 2029 ~USD 19.13 Million
  • Country China

China AI in Precision Medicine Market Overview

Rapid Market Expansion :

China's AI in Precision Medicine market is projected to grow from $4.21 billion in 2024 to $19.13 billion by 2029, representing a 22.3% CAGR, driven by government digitalization initiatives and increased healthcare spending.

Government-Backed Innovation :

China's strategic investments in AI infrastructure and healthcare digitalization, supported by national policies, are accelerating adoption of precision medicine technologies across hospitals and research institutions.

Rising Healthcare Expenditure :

Increased government and private sector healthcare spending in China is fueling demand for AI-powered diagnostic and treatment solutions to improve patient outcomes and operational efficiency.

Technology Integration :

Chinese healthcare providers are rapidly integrating AI algorithms for genomic analysis, drug discovery, and personalized treatment planning, positioning China as a key innovation hub in precision medicine.

China AI in Precision Medicine Market Dynamics

  • The country's commitment to modernizing its healthcare system, combined with rising healthcare expenditure and a large patient population, creates significant opportunities for AI-driven precision medicine solutions.
  • Chinese hospitals and research institutions are increasingly adopting AI technologies for genomic sequencing, predictive analytics, and personalized treatment protocols.
  • This expansion is further accelerated by China's competitive advantage in AI development and data analytics capabilities.
  • By 2029, the market is expected to reach $19.13 billion, reflecting strong demand from both public and private healthcare sectors seeking to enhance diagnostic accuracy and treatment efficacy..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • China's AI in Precision Medicine market will grow from $4.21B (2024) to $19.13B (2029) at a 22.3% CAGR, outpacing many global peers.
        • Government support and healthcare digitalization initiatives are accelerating AI adoption across China's medical institutions.
        • China's large patient population and genomic research capabilities create substantial demand for AI-powered diagnostic and therapeutic solutions.
        • Machine learning integration in clinical workflows and drug discovery will drive significant market expansion throughout China by 2029.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        China AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        CHINA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030

        Segment202220232024202520262027202820292030CAGR (%)
        HEALTHCARE PROVIDERS12.7316.7922.1429.1738.4250.5966.5987.6115.2131.6
        MEDICAL DEVICE/EQUIPMENT COMPANIES7.6410.0313.1617.2722.6429.6838.8850.9366.6831
        OTHER END USERS2.863.724.846.288.1610.5913.7417.8223.1129.8
        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES10.0312.9416.6821.527.735.6845.9359.1176.0328.8
        RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS6.428.2210.5113.4417.1721.9428.0135.7645.6327.7
        TOTAL39.6951.767.3387.66114.1148.48193.16251.22326.6530.1

        Target Audience

        • Healthcare Technology Companies : Need China market insights to develop localized AI precision medicine solutions, understand adoption barriers, and identify partnership opportunities with Chinese hospitals and research institutions.
        • Pharmaceutical & Biotech Firms : Require detailed market analysis to guide drug discovery investments, personalized medicine development, and commercialization strategies tailored to China's regulatory environment and patient demographics.
        • Healthcare Investors & PE Firms : Seek comprehensive China market data to evaluate investment opportunities, assess portfolio company growth potential, and identify emerging precision medicine startups and technology providers.
        • Hospital & Healthcare Systems : Need market intelligence to benchmark AI adoption rates, evaluate precision medicine technology vendors, and develop digital transformation roadmaps aligned with China's healthcare modernization goals.
        • Government & Policy Makers : Require market insights to inform healthcare policy decisions, allocate resources for AI infrastructure development, and assess the effectiveness of precision medicine initiatives in improving patient outcomes.

        Reasons to Buy this Report

        • Market Size & Growth Validation : Obtain precise market valuation data for China ($4.21B in 2024) and verified forecasts through 2029, enabling accurate business planning and investment decisions in the region's high-growth precision medicine sector.
        • Competitive Intelligence : Understand China-specific market dynamics, government initiatives, and technology adoption patterns to identify competitive advantages and strategic positioning opportunities against local and international players.
        • Investment & Expansion Strategy : Access detailed insights on China's healthcare digitalization roadmap and AI infrastructure investments to guide market entry strategies, partnership development, and resource allocation decisions.
        • Regulatory & Policy Landscape : Gain comprehensive understanding of China's government-backed innovation programs, healthcare policies, and regulatory frameworks shaping precision medicine adoption and market opportunities.
        • Stakeholder Alignment : Leverage China-specific market data to align internal teams, secure stakeholder buy-in, and justify investment in precision medicine initiatives within the rapidly expanding Chinese healthcare ecosystem.

        Frequently asked questions

        What is the current market size of AI in Precision Medicine in China?

        China's AI in Precision Medicine market was valued at $4.21 billion in 2024 and is projected to reach $19.13 billion by 2029.

        What is the expected growth rate for China's AI in Precision Medicine market?

        China's market is expected to grow at a compound annual growth rate (CAGR) of 22.3% from 2024 to 2029.

        What factors are driving growth in China's AI Precision Medicine sector?

        Key drivers include government healthcare digitalization initiatives, rising healthcare expenditure, large patient populations, genomic research capabilities, and increasing adoption of AI-powered diagnostic tools across China's medical institutions.

        How will China's AI in Precision Medicine market evolve by 2029?

        By 2029, China is expected to see widespread integration of machine learning in clinical decision-making, drug discovery, and patient stratification, with AI solutions becoming standard across hospitals and research institutions.

        Why is China significant in the global AI Precision Medicine market?

        China's large patient population, substantial venture capital investment, government biotech support, and rapid healthcare digitalization make it a critical growth engine reshaping global precision medicine standards.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status